Recce Pharmaceuticals (OP: RECEF )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Recce Pharma welcomes approval for faster RECCE327 infusion rate
October 26, 2023
Recce Pharma welcomes approval for faster RECCE327 infusion rate
October 26, 2023
Recce Pharma begins dosing in diabetic foot infection trial
August 23, 2023
Recce Pharma begins dosing in diabetic foot infection trial
August 23, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|